These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 14978457)

  • 1. Anxiety and depression in the elderly: implications for diagnosis and treatment.
    Dunner DL
    CNS Spectr; 2003 Dec; 8(12 Suppl 3):5. PubMed ID: 14978457
    [No Abstract]   [Full Text] [Related]  

  • 2. [Depression after age 50. Clinical case].
    Frémont P
    Encephale; 2000 Nov; 26 Spec No 5():61-2. PubMed ID: 11217527
    [No Abstract]   [Full Text] [Related]  

  • 3. [Selective serotonin and noradrenaline reuptake inhibitors: a step forward in the treatment of depression?].
    Möller HJ; Bauer M; Fritze J; Haen E; Laux G; Müller WE; Rüther E
    MMW Fortschr Med; 2005 Jan; 147(3):43-5. PubMed ID: 15727113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anxiety and depression: which antidepressants treat both at the same time?].
    Laflamme F
    Perspect Infirm; 2010; 7(2):43. PubMed ID: 21744603
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of antidepressants to treat depression in children and adolescents].
    Desombre H; Paccalin C; Revol O; Fourneret P
    Arch Pediatr; 2006 Jun; 13(6):711-3. PubMed ID: 16697608
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitors in mixed anxiety-depression.
    Berk M
    Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S41-5. PubMed ID: 11110018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression with anxiety and atypical depression.
    Liebowitz MR
    J Clin Psychiatry; 1993 Feb; 54 Suppl():10-4; discussion 15. PubMed ID: 8444829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic action and efficiency of fevarin (fluvoxamine) in patients with non-psychotic anxious and apathic-adynamic depressions].
    Neznamov GG; Siuniakov SA; Teleshova ES; Dorofeeva OA; Chumakov DB; Davydova IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(8):19-24. PubMed ID: 11552628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxious depression and response to treatment.
    Nelson JC
    Am J Psychiatry; 2008 Mar; 165(3):297-9. PubMed ID: 18316424
    [No Abstract]   [Full Text] [Related]  

  • 10. Understanding the neurobiology of comorbidity in anxiety disorders.
    Nutt DJ; Stein DJ
    CNS Spectr; 2006 Oct; 11(10 Suppl 12):13-20. PubMed ID: 17008826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-daily venlafaxine XR compared with fluoxetine in outpatients with depression and anxiety.
    Judge R; Wagner BE
    J Clin Psychiatry; 1999 Nov; 60(11):795-6. PubMed ID: 10584775
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clomipramine and other serotonin reuptake inhibitors in the treatment of depressed mood, anxiety and impaired impulse control].
    Eriksson E
    Psychiatr Pol; 1994; 28(5):601-12. PubMed ID: 7991713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of patients with depression associated with anxiety symptoms.
    Nutt D
    J Clin Psychiatry; 1997; 58 Suppl 8():11-6. PubMed ID: 9236730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Depression and anxiety in the elderly still underdiagnosed. SSRI preparations in conjunction with psychotherapy provide effective treatment].
    Gottfries CG; Karlsson I
    Lakartidningen; 2001 Feb; 98(8):821-7. PubMed ID: 11265567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SSRIs in anxious-agitated depression: a post-hoc analysis of 279 patients.
    Filteau MJ; Baruch P; Lapierre YD; Bakish D; Blanchard A
    Int Clin Psychopharmacol; 1995 Mar; 10(1):51-4. PubMed ID: 7622805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can recovery from depression be achieved?
    Shelton RC; Tomarken AJ
    Psychiatr Serv; 2001 Nov; 52(11):1469-78. PubMed ID: 11684742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression and anxiety: pharmacological treatment in general practice.
    Ellen S; Selzer R; Norman T; Blashki G
    Aust Fam Physician; 2007 Apr; 36(4):222-8. PubMed ID: 17392933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment response and redefining diagnostic boundaries.
    Hollander E
    CNS Spectr; 2008 Dec; 13(12):1020-1. PubMed ID: 19179937
    [No Abstract]   [Full Text] [Related]  

  • 19. Survivors of torture presenting at an anxiety disorders clinic: symptomatology and pharmacotherapy.
    Bouwer C; Stein DJ
    J Nerv Ment Dis; 1998 May; 186(5):316-8. PubMed ID: 9612450
    [No Abstract]   [Full Text] [Related]  

  • 20. Examination of the decline in symptoms of anxiety and depression in generalized anxiety disorder: impact of anxiety sensitivity on response to pharmacotherapy.
    Olatunji BO; Feldman G; Smits JA; Christian KM; Zalta AK; Pollack MH; Simon NM
    Depress Anxiety; 2008; 25(2):167-71. PubMed ID: 17335002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.